Latest Insider Transactions at Icosavax, Inc. (ICVX)
This section provides a real-time view of insider transactions for Icosavax, Inc. (ICVX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Icosavax, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Icosavax, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 04
2023
|
Niranjan Kanesa Thasan |
SELL
Open market or private sale
|
Direct |
106,373
-32.2%
|
$1,595,595
$15.7 P/Share
|
|
Jan 04
2023
|
Niranjan Kanesa Thasan |
BUY
Exercise of conversion of derivative security
|
Direct |
106,373
+7.53%
|
$531,865
$5.7 P/Share
|
|
Dec 23
2022
|
Adam K. Simpson |
BUY
Exercise of conversion of derivative security
|
Direct |
14,369
+5.66%
|
$0
$0.84 P/Share
|
|
Dec 21
2022
|
Adam K. Simpson |
SELL
Open market or private sale
|
Direct |
66,764
-22.87%
|
$534,112
$8.96 P/Share
|
|
Dec 15
2022
|
Douglas Holtzman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
19,648
-87.56%
|
$216,128
$11.14 P/Share
|
|
Sep 08
2022
|
Elizabeth Bekiroglu General Counsel & Corp. Sec. |
SELL
Open market or private sale
|
Direct |
1,813
-1.64%
|
$7,252
$4.87 P/Share
|
|
Aug 02
2022
|
Adam K. Simpson |
SELL
Open market or private sale
|
Direct |
1,904
-0.65%
|
$11,424
$6.7 P/Share
|
|
Aug 02
2022
|
Thomas Joseph Russo |
SELL
Open market or private sale
|
Direct |
495
-1.0%
|
$2,970
$6.7 P/Share
|
|
Aug 02
2022
|
Charles E Richardson SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
371
-0.22%
|
$2,226
$6.7 P/Share
|
|
Aug 02
2022
|
Niranjan Kanesa Thasan |
SELL
Open market or private sale
|
Direct |
543
-0.23%
|
$3,258
$6.7 P/Share
|
|
Aug 02
2022
|
Douglas Holtzman Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
453
-0.15%
|
$2,718
$6.7 P/Share
|
|
Aug 02
2022
|
Cassia Cearley |
SELL
Open market or private sale
|
Direct |
303
-0.23%
|
$1,818
$6.7 P/Share
|
|
Aug 01
2022
|
Adam K. Simpson |
SELL
Open market or private sale
|
Direct |
7,017
-2.33%
|
$42,102
$6.64 P/Share
|
|
Aug 01
2022
|
Thomas Joseph Russo |
SELL
Open market or private sale
|
Direct |
1,825
-3.56%
|
$10,950
$6.64 P/Share
|
|
Aug 01
2022
|
Charles E Richardson SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
1,368
-0.82%
|
$8,208
$6.64 P/Share
|
|
Aug 01
2022
|
Niranjan Kanesa Thasan |
SELL
Open market or private sale
|
Direct |
2,001
-0.83%
|
$12,006
$6.64 P/Share
|
|
Aug 01
2022
|
Douglas Holtzman Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,337
-3.08%
|
$56,022
$6.64 P/Share
|
|
Aug 01
2022
|
Cassia Cearley |
SELL
Open market or private sale
|
Direct |
1,118
-0.84%
|
$6,708
$6.64 P/Share
|
|
Jul 29
2022
|
Adam K. Simpson |
SELL
Open market or private sale
|
Direct |
2,456
-0.81%
|
$17,192
$7.11 P/Share
|
|
Jul 29
2022
|
Thomas Joseph Russo |
SELL
Open market or private sale
|
Direct |
639
-1.23%
|
$4,473
$7.11 P/Share
|
|
Jul 29
2022
|
Charles E Richardson SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
479
-0.29%
|
$3,353
$7.11 P/Share
|
|
Jul 29
2022
|
Niranjan Kanesa Thasan |
SELL
Open market or private sale
|
Direct |
701
-0.29%
|
$4,907
$7.11 P/Share
|
|
Jul 29
2022
|
Douglas Holtzman Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
585
-0.19%
|
$4,095
$7.11 P/Share
|
|
Jul 29
2022
|
Cassia Cearley |
SELL
Open market or private sale
|
Direct |
391
-0.29%
|
$2,737
$7.11 P/Share
|
|
Jul 01
2022
|
Adam K. Simpson |
BUY
Exercise of conversion of derivative security
|
Direct |
7,185
+2.31%
|
$0
$0.84 P/Share
|
|
Jun 10
2022
|
Mark Mcdade |
BUY
Grant, award, or other acquisition
|
Direct |
5,543
+9.04%
|
-
|
|
Jun 10
2022
|
Heidi Fields |
BUY
Grant, award, or other acquisition
|
Direct |
5,543
+27.94%
|
-
|
|
Jun 10
2022
|
John W. Shiver |
BUY
Grant, award, or other acquisition
|
Direct |
2,399
+18.04%
|
-
|
|
Jun 10
2022
|
Ann M Veneman |
BUY
Grant, award, or other acquisition
|
Direct |
5,543
+28.3%
|
-
|
|
Jun 10
2022
|
Jim Wassil |
BUY
Grant, award, or other acquisition
|
Direct |
11,087
+50.0%
|
-
|
|
Jun 10
2022
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
5,543
+50.0%
|
-
|
|
Apr 01
2022
|
Mark Mcdade |
BUY
Open market or private purchase
|
Direct |
42,225
+45.66%
|
$295,575
$7.1 P/Share
|
|
Mar 29
2022
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
8,900
+0.15%
|
$35,600
$4.75 P/Share
|
|
Mar 28
2022
|
Adam K. Simpson |
BUY
Exercise of conversion of derivative security
|
Direct |
4,789
+2.13%
|
$0
$0.84 P/Share
|
|
Mar 28
2022
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
175,318
+2.86%
|
$701,272
$4.53 P/Share
|
|
Mar 18
2022
|
Cassia Cearley |
BUY
Exercise of conversion of derivative security
|
Direct |
35,137
+20.83%
|
$0
$0.84 P/Share
|
|
Mar 07
2022
|
Cassia Cearley |
SELL
Open market or private sale
|
Direct |
10,000
-4.63%
|
$170,000
$17.47 P/Share
|
|
Feb 18
2022
|
Douglas Holtzman Chief Scientific Officer |
SELL
Bona fide gift
|
Indirect |
20,000
-47.13%
|
-
|
|
Feb 14
2022
|
Charles E Richardson SVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
72,561
+16.37%
|
$0
$0.94 P/Share
|
|
Feb 10
2022
|
Elizabeth Bekiroglu General Counsel & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
82,992
+42.84%
|
-
|
|
Feb 10
2022
|
Cassia Cearley |
BUY
Grant, award, or other acquisition
|
Direct |
21,256
+16.39%
|
-
|
|
Feb 10
2022
|
Douglas Holtzman Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,485
+6.03%
|
-
|
|
Feb 10
2022
|
Niranjan Kanesa Thasan |
BUY
Grant, award, or other acquisition
|
Direct |
19,485
+7.44%
|
-
|
|
Feb 10
2022
|
Charles E Richardson SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
15,942
+14.39%
|
-
|
|
Feb 10
2022
|
Adam K. Simpson |
BUY
Grant, award, or other acquisition
|
Direct |
75,578
+20.6%
|
-
|
|
Feb 10
2022
|
Thomas Joseph Russo |
BUY
Grant, award, or other acquisition
|
Direct |
17,714
+25.45%
|
-
|
|
Feb 02
2022
|
Niranjan Kanesa Thasan |
BUY
Exercise of conversion of derivative security
|
Direct |
52,752
+11.0%
|
$0
$0.94 P/Share
|
|
Jan 26
2022
|
Adam K. Simpson |
BUY
Exercise of conversion of derivative security
|
Direct |
90,693
+18.05%
|
$0
$0.94 P/Share
|
|
Jan 03
2022
|
John W. Shiver |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+50.0%
|
-
|
|
Dec 31
2021
|
Douglas Holtzman Chief Scientific Officer |
SELL
Bona fide gift
|
Indirect |
10,000
-19.07%
|
-
|